COXEVAC® is a phase one inactivated vaccine against Coxiella burnetii. Dose is 2ml for goats and 4 ml for cattle given under the skin. The primary course is 2 injections given 3 weeks apart.
COXEVAC® is a unique vaccine containing ultra-purified phase I C. burnetii resulting in an optimal immune response. A vaccine protocol needs to be implemented over at least 3 years to maximally reduce shedding and therefore environmental contamination and disease.
Reduces abortion rate – in one study the abortion rate was reduced from 75% to 6%29.
Reduces the duration of shedding in milk, faeces and vaginal mucus29.
Reduces the risk of abortion by 30%10.
Reduces the risk of animals becoming shedders:
Reduces the environmental burden31.
Reduces the bacterial load across the herd32.
COXEVAC® suspension for injection for cattle, sheep and goats contains inactivated Coxiella burnetti, strain Nine Mile ≥72 QF Unit*/ml. *Q-fever Unit: relative potency of phase I antigen measured by ELISA in comparison with a reference item. LEGAL CATEGORY: UK POM-V. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications.
Prescriptions decisions are for the person issuing the prescription alone. Further information is available from the SPC or on the datasheet at www.noahcompendium.co.uk or upon request.